This inventor holds 1 USPTO granted patent. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Adam Smith Murray
Introduction
Adam Smith Murray is a notable inventor based in Lynnwood, WA (US). He has made significant contributions to the field of biotechnology, particularly in the design of cell-based screening assays. His innovative approach has the potential to enhance the efficiency and effectiveness of experimental designs in this area.
Latest Patents
Adam holds a patent for "Methods and user interfaces for designing cell-based screening assay experiments." This patent describes a method that involves receiving inputs through a graphical user interface to define various parameters for conducting cell-based screening assays. The method includes identifying template plate definitions, disease reagents, treatment reagents, and generating a design for the experiment based on these inputs. This innovation aims to streamline the process of designing complex experiments, making it easier for researchers to conduct their work.
Career Highlights
Adam is currently employed at Recursion Pharmaceuticals, Inc., where he applies his expertise in biotechnology and assay design. His work at Recursion Pharmaceuticals focuses on leveraging technology to improve drug discovery processes. With a patent portfolio that includes 1 patent, Adam has established himself as a valuable contributor to the field.
Collaborations
Some of Adam's coworkers include Anthus John Williams and Benjamin Judson Sukow. Their collaborative efforts contribute to the innovative environment at Recursion Pharmaceuticals, fostering advancements in biotechnology.
Conclusion
Adam Smith Murray's contributions to the field of biotechnology through his innovative patent and work at Recursion Pharmaceuticals highlight the importance of creativity and collaboration in scientific research. His efforts are paving the way for more efficient experimental designs in cell-based screening assays.